Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.

Flubromazepam

Подписчиков: 0, рейтинг: 0
Flubromazepam
Flubromazepam.svg
Clinical data
Routes of
administration
Oral
Legal status
Legal status
Pharmacokinetic data
Elimination half-life 106 hours
Identifiers
  • 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C15H10BrFN2O
Molar mass 333.160 g·mol−1
3D model (JSmol)
  • BrC1=CC(C(C2=CC=CC=C2F)=NC3)=C(C=C1)NC3=O
  • InChI=1S/C15H10BrFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)
  • Key:ZRKDDZBVSZLOFS-UHFFFAOYSA-N

Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug.

It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.

An alternate isomer, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one or "iso-flubromazepam", may have been sold under the same name.

Alternate isomer

Legal status

United Kingdom

In the UK, flubromazepam has been classified as a Class C drug by the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.

United States

Flubromazepam, clonazolam, and flubromazolam are Schedule I controlled substances under Virginia State Law.

See also


Новое сообщение